Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The humanized mouse is a mouse which possess functioning human genes, cells, tissues and organs in case of biological along with medical research for human therapeutics. These mouse models are used to model the human immune system in scenarios of health and pathology. The use of models for identification of immunodeficiency disorder, cancers and other rare diseases. The human proteins is expressed while the mouse protein is suppressed in all cells and tissues. Humanized mouse models are important tool essential for conducing preclinical research, mimic human pathological conditions.
The North America humanized mouse models market is witnessing lucrative growth during the forecast period of 2019 - 2028. The mouse models needs accurate risk assessment and thorough analysis for preserving the physiological expression and regulation of the human gene inserted into the mouse genome. The key factors such as increase in research and development activities is propelling growth of North America humanized mouse models market. The rising prevalence of cancer is also boosting growth of North America humanized mouse models market. However, stringent regulatory policies is hindering growth of North America humanized mouse models.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the humanized mouse models market. In addition, complete analysis of changes on humanized mouse models expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on North America economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The rising incidences of various diseases and viral infections such as COVID-19 increases the demand for humanized mouse models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of humanized mouse models market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of humanized mouse models market during COVID-19 period.
The North America humanized mouse models market is bifurcated into the type, application, end user and country.
The types such as genetic humanized mouse models and cell-based humanized mouse models is comprised in the North America humanized mouse models market. The cell-based humanized mouse is also contributing to the growth of North America humanized mouse models market. The rising prevalence of cancer is propelling growth of North America humanized mouse models market. The increasing immunodeficiency disorders is also boosting growth of North America humanized mouse models market.
The applications such as immunology and infectious diseases, neuroscience, oncology, haematopoiesis, toxicology and other are comprised in the North America humanized mouse models market. The toxicological applications is also contributing to the growth of North America humanized mouse models market. The rising incidences of drug toxicities is boosting growth of North America humanized mouse models market. The growing product development is also refuelling growth of North America humanized mouse models market.
The end user such as pharmaceutical and biotechnology companies, contract research organizations and academic and research institutes are comprised in the North America humanized mouse models market. The contract research organizations are also contributing to the growth of North America humanized mouse models market. The rising outsourcing of pharmaceutical is propelling growth of North America humanized mouse models market.
The North America humanized mouse models market is studied for key countries such as United States, Mexico and Canada. In which United States is anticipated to dominate the market in 2020. The rising research and development activities is propelling growth of North America humanized mouse models market. The rising healthcare infrastructure is also boosting growth of North America humanized mouse models market.
Key Players in Humanized Mouse Models Market
The major key players in humanized mouse models market are The Jackson Laboratory, Taconic Biosciences Inc., Harbour Biomed, Humurine Technologies Inc., Vitalstar Biotechnology Co. Ltd., Crown Bioscience Inc., Ingenious Targeting Laboratory, Axenis S.A.S., Trans Genic Inc. and Genoway S.A. among others.
January 2021: The Champion Oncology Inc., a well-known global oncology technology company which is transforming drug discovery and development by the data driven research strategies announced the expansion of its Lumin Bioinformatics SaaS program.
December 2020: The Perkin Elmer Inc., and Horizon Discovery Group plc announced the agreement on the terms of a recommended all-cash offer in Perkin Elmer will acquire Horizon.
January 2020: The Taconic Biosciences, a global leader in the development of drug discovery animal model has launched a new model generation facility in Leverkusen, Germany.
January 2020: The H.I.G. Capital announced that one of their affiliates has joined forces with the management team of Taconic Biosciences inc., for supporting company’s growth as the leading provider of research models and services to the pharmaceutical, biotechnology and contract research organizations.
The report analyses the humanized mouse models based on the type, application, end user and country. The various types of humanized mouse models covered in the report are genetic humanized mouse models and cell-based humanized mouse models. By Application, the market is segmented into the immunology and infectious diseases, neuroscience, oncology, haematopoiesis, toxicology and other. Based on end user, the market is segmented into the pharmaceutical and biotechnology companies, contract research organization and academic and research institutes. The report also analyses the impact of COVID-19 on the market and it found that the rising incidences of various diseases and viral infections such as COVID-19 increases the demand for humanized mouse models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of humanized mouse models market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of humanized mouse models market during COVID-19 period. The report also analyses the major key players operating in the market.
Why to buy this report:
